Comparison of the LIAISON® CMV IgG Avidity II and the VIDAS® CMV IgG Avidity II assays for the diagnosis of primary infection in pregnant women

Journal of Clinical Virology

Volumn 72, Issue , 2015, Pages 46-48

  Sellier, Yann ^a,b   Guilleminot, Tiffany ^a,b   Ville, Yves ^a,b   Leruez Ville, Marianne ^a,b  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Cytomegalovirus; IgG avidity; LIAISON; Primary infection; VIDAS

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ARTICLE; CONTROLLED STUDY; DIAGNOSTIC KIT; FEMALE; GESTATIONAL AGE; HUMAN; IMMUNOASSAY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; PREGNANT WOMAN; PRIMARY INFECTION; PRIORITY JOURNAL; SEROCONVERSION; ANTIBODY AFFINITY; BLOOD; COMPARATIVE STUDY; CYTOMEGALOVIRUS INFECTIONS; EVALUATION STUDY; LABORATORY AUTOMATION; PREGNANCY; PROCEDURES; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; SEROLOGY;

ANTIBODY AFFINITY; AUTOMATION, LABORATORY; CYTOMEGALOVIRUS INFECTIONS; FEMALE; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PREGNANCY; PREGNANT WOMEN; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEROLOGIC TESTS;

EID: 84946401938     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2015.08.018     Document Type: Article

References (12)

1. Blackburn N.K., Besselaar T.G., Schoub B.D., O'Connell K.F. Differentiation of primary cytomegalovirus infection from reactivation using the urea denaturation test for measuring antibody avidity. J. Med. Virol. 1991, 33(January (1)):6-9.
2. Grangeot-Keros L., Mayaux M.J., Lebon P., Freymuth F., Eugene G., Stricker R., et al. Value of cytomegalovirus (CMV) IgG avidity index for the diagnosis of primary CMV infection in pregnant women. J. Infect. Dis. 1997, 175(April (4)):944-946.
3. Lazzarotto T., Gabrielli L., Lanari M., Guerra B., Bellucci T., Sassi M., et al. Congenital cytomegalovirus infection: recent advances in the diagnosis of maternal infection. Hum. Immunol. 2004, 65(May (5)):410-415.
4. Jacquemard F., Yamamoto M., Costa J.-M., Romand S., Jaqz-Aigrain E., Dejean A., et al. Maternal administration of valaciclovir in symptomatic intrauterine cytomegalovirus infection. BJOG Int. J. Obstet. Gynaecol. 2007, 114(September (9)):1113-1121.
5. Nigro G., Adler S.P., La Torre R., Best A.M., Congenital Cytomegalovirus Collaborating Group Passive immunization during pregnancy for congenital cytomegalovirus infection. N. Engl. J. Med. 2005, 353(September (13)):1350-1362.
6. Revello M.G., Lazzarotto T., Guerra B., Spinillo A., Ferrazzi E., Kustermann A., et al. A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. N. Engl. J. Med. 2014, 370(April (14)):1316-1326.
7. Lagrou K., Bodeus M., Van Ranst M., Goubau P. Evaluation of the new architect cytomegalovirus immunoglobulin M (IgM), IgG, and IgG avidity assays. J. Clin. Microbiol. 2009, 47(June (6)):1695-1699.
8. Revello M.G., Genini E., Gorini G., Klersy C., Piralla A., Gerna G. Comparative evaluation of eight commercial human cytomegalovirus IgG avidity assays. J. Clin. Virol. 2010, 48(August (4)):255-259.
9. Leruez-Ville M., Sellier Y., Salomon L.J., Stirnemann J.J., Jacquemard F., Ville Y. Prediction of fetal infection in cases with cytomegalovirus immunoglobulin M in the first trimester of pregnancy: a retrospective cohort. Clin. Infect. Dis. 2013, 56(May (10)):1428-1435.
10. Lumley S., Patel M., Griffiths P.D. The combination of specific IgM antibodies and IgG antibodies of low avidity does not always indicate primary infection with cytomegalovirus. J. Med. Virol. 2014, 86(May (5)):834-837.
11. ® cytomegalovirus (CMV) IgG avidity assay: determination of new cut-off values based on the study of kinetics of CMV-IgG maturation. J. Clin. Virol. 2013, 56(February (2)):118-123.
12. Berth M., Grangeot-Keros L., Heskia F., Dugua J.-M., Vauloup-Fellous C. Analytical issues possibly affecting the performance of commercial human cytomegalovirus IgG avidity assays. Eur. J. Clin. Microbiol. Infect. Dis. 2014, 33(September (9)):1579-1584.